EXR
57
2
FRT
50
5
VMC
59
2
MCO
77
4
PH
77
2
ABT
50
2
ADP
70
2
NTRS
74
-3
FTI
79
15
BWA
57
-4
HUM
48
-4
JPM
78
3
MOS
52
-6
DOW
47
-3
EQT
57
-2
HON
70
-9
BAX
51
-2
CB
57
3
ADT
74
8
MSFT
64
3
EXR
57
2
FRT
50
5
VMC
59
2
MCO
77
4
PH
77
2
ABT
50
2
ADP
70
2
NTRS
74
-3
FTI
79
15
BWA
57
-4
HUM
48
-4
JPM
78
3
MOS
52
-6
DOW
47
-3
EQT
57
-2
HON
70
-9
BAX
51
-2
CB
57
3
ADT
74
8
MSFT
64
3
Financhill
Back

Dare Bioscience 10K Form

Sell
17

DARE
Dare Bioscience

Last Price:
$2.41
Seasonality Move:
-19.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DARE News And Ratings

See the #1 stock for the next 7 days that we like better than DARE

DARE Financial Statistics

Sales & Book Value

Annual Sales: $9.8K
Cash Flow: $-5.6M
Price / Cash Flow: 3.37
Annual Sales: $-1.08
Price / Book: 11.45

Profitability

EPS (TTM): -0.18060
Net Income (TTM): $-1.7M
Gross Margin: $10K
Return on Equity: 0%
Return on Assets: -8.79%

Dare Bioscience Earnings Forecast

Key Dare Bioscience Financial Ratios

  • The Gross Profit Margin over the past 2 years for DARE is 166.67%.
  • The Selling, General & Administrative Expenses for DARE have been equal to 93,620.25% of Gross Profit Margin.
  • The Research & Development expenses have been 145,247.55% of Revenue.
  • Per Share Earnings over the last 13 years have been positive in 10 years.

Dare Bioscience Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: DARE
CUSIP: 23666P
Website: darebioscience.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.56
Quick Ratio: 0.49

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

DARE Technical Analysis vs Fundamental Analysis

Sell
17
Dare Bioscience (DARE) is a Sell

Is Dare Bioscience a Buy or a Sell?

  • Dare Bioscience stock is rated a Sell
    The current Dare Bioscience [DARE] share price is $2.40. The Score for DARE is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.